Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Debt Securities, Available-for-sale, Amortized Cost

1.8 / 5 stars · 31/86 Roast Me

VivoSim Labs, Inc. Debt Securities, Available-for-sale, Amortized Cost

VivoSim Labs, Inc. (VIVS) had Debt Securities, Available-for-sale, Amortized Cost of $497.00 thousand as of 2024-12-31, per its 10-Q filed 2025-02-19.

Financial Statements › Notes

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2025-06-05

  • 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $497.00K.
  • 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost $994.00K.
  • 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $1.49M.
  • 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $996.00K; Debt Securities, Available-for-sale, Amortized Cost as first filed $997.00K.
Period endDebt Securities, Available-for-sale, Amortized CostDebt Securities, Available-for-sale, Amortized Cost as first filed
2024-12-31$497.00K
10-Q · filed 2025-02-19
2024-09-30$994.00K
10-Q · filed 2024-11-08
2024-06-30$1.49M
10-Q · filed 2024-08-05
2024-03-31$996.00K
10-K · filed 2025-06-05
$997.00K
10-K · filed 2024-05-31
2023-12-31$2.00M
10-Q · filed 2024-02-08
2023-09-30$2.99M
10-Q · filed 2023-11-09
2023-06-30$4.99M
10-Q · filed 2023-08-10
2023-03-31$4.94M
10-K · filed 2024-05-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70